Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
These are standard precautions and regulatory review will determine the full contraindication and warning profile ahead of any potential market authorisation
When applied on STORM cohort, KUSOR gene signature was able to predict patients who do not recur on adjuvant setting of sorafenib treatment after HCC resection or ablation with sensitivity of 91% and specificity of 74%
B12 Slows Functional Decline in Early-stage ALS, Data Show Written by | Treatment with ultrahigh-dose methylcobalamin the physiologically active form of vitamin B12 effectively slowed functional decline in people with early-stage amyotrophic lateral sclerosis (ALS) and moderate progression, data from a small Phase 3 trial in Japan show
How long is a treatment
US$ 20.48
US$ 21.61
US$ 21.23
US$ 28.91
US$ 26.79
US$ 29.52
US$ 22.16
